Skip to content
10-K

Annual Report

NU-MED PLUS, INC. NUMD

0001543637-26-000005

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Apr 15, 2026 83.55M sh
Shares Diluted FY 2025 · Dec 31, 2025 83.55M sh
Shares Diluted FY 2025 · Dec 31, 2024 83.55M sh
Operating Cash Flow FY 2025 · Dec 31, 2025 −$47.98K
Operating Cash Flow FY 2025 · Dec 31, 2024 −$4.43K
Stockholders Equity FY 2025 · Dec 31, 2025 −$271.28K
Stockholders Equity FY 2025 · Dec 31, 2024 −$215.1K
Stockholders Equity FY 2025 · Dec 31, 2023 −$146.75K
Current Liabilities FY 2025 · Dec 31, 2025 $279.19K
Current Liabilities FY 2025 · Dec 31, 2024 $224.47K
Total Liabilities FY 2025 · Dec 31, 2025 $279.19K
Total Liabilities FY 2025 · Dec 31, 2024 $224.47K
Current Assets FY 2025 · Dec 31, 2025 $7.91K
Current Assets FY 2025 · Dec 31, 2024 $9.37K
Total Assets FY 2025 · Dec 31, 2025 $7.91K
Total Assets FY 2025 · Dec 31, 2024 $9.37K
Eps Diluted FY 2025 · Dec 31, 2025 $0.00
Eps Diluted FY 2025 · Dec 31, 2024 $0.00
Eps Basic FY 2025 · Dec 31, 2025 $0.00
Eps Basic FY 2025 · Dec 31, 2024 $0.00
Sga Expense FY 2025 · Dec 31, 2025 $23.12K
Sga Expense FY 2025 · Dec 31, 2024 $34.32K
Net Income FY 2025 · Dec 31, 2025 −$56.18K
Net Income FY 2025 · Dec 31, 2024 −$68.35K
Operating Income FY 2025 · Dec 31, 2025 −$48.96K
Operating Income FY 2025 · Dec 31, 2024 −$63.33K